Collectively, our findings suggest that circRAPGEF1 reprograms aspartate metabolism, subsequently activating the S6K/CAD signaling pathway and exacerbating the malignant phenotype of HCC cells. This evidence concerns the gene RPS6KB1 and hepatocellular carcinoma.